New Crohn's Breakthrough Targets Scar Tissue

0:00On April 5th, scientists just dropped a breakthrough on Crohn's disease, zeroing in on what fuel scar tissue build up in the intestines. They spotted clusters of immune cells in the gut that crank up nearby cells to pump out excess collagen, causing fibrosis. This scarry narrows the bowel, blocks it, and often forces surgery. A major headache for Crohn's patients. Crohn's hits the digestive tract with chronic inflammation that over time turns into this tough fibrosis. Right now, treatments mostly fight the inflammation, but ignore the scarring, leaving folks vulnerable to those nasty complications. Experts are buzzing because this could unlock new drugs to halt or slow fibrosis before it wrecks the gut. Patients deal with lifelong damage from scarring, and current meds don't touch it, so real hope is building for targeted fixes. Diving deeper, the team from University of Edinburgh analyzed gut tissues from patients, especially the Ilium where Crohn's loves to strike. During single cell RNA sequencing on fresh samples, they linked immune cell clusters to

1:00endothelial cells lining blood vessels, which signal collagen, makers to go overboard. This UKY collab, backed by the Helmsley Charitable Trust, spells out fresh pathways for therapies in the Journal of Pathology. This is stepped toward tackling not just the fire of inflammation, but the lasting burn of scars.